Trials / Recruiting
RecruitingNCT07385534
Effects of Lower Body EMS Training in Postmenopausal Women
Effects of Lower Body Electrical Muscle Stimulation Training on Body Composition, Muscle Function, and Arteriosclerosis Markers in Postmenopausal Women
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (estimated)
- Sponsor
- Seoul National University · Academic / Other
- Sex
- Female
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the effects of a 6-week lower body Electrical Muscle Stimulation (EMS) training program on body composition, muscle function, and arteriosclerosis markers in postmenopausal women. Menopause is associated with a rapid decline in estrogen, which increases the risk of sarcopenia (muscle loss) and arterial stiffness (cardiovascular disease). While resistance training is effective for these conditions, participation rates among postmenopausal women are often low. This study investigates whether applying EMS during lower body resistance exercises provides superior benefits compared to resistance training alone or no intervention. Participants will be randomized into three groups: 1. Lower-body EMS combined with Resistance Training Group 2. Resistance Training Only Group 3. Control Group (No intervention) The study aims to verify the efficacy of EMS as a time-efficient and effective alternative exercise modality for improving vascular and musculoskeletal health in this population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lower-body Electromyostimulation (LB-EMS) device | Electrical stimulation applied to the lower body muscles (85Hz, 350µs) during the main exercise phase |
| BEHAVIORAL | Lower Body Resistance Training | A 50-minute session consisting of a 10-minute warm-up, 30 minutes of main lower body resistance training (4 types of machine-based exercises per session), and a 10-minute cool-down |
Timeline
- Start date
- 2025-12-26
- Primary completion
- 2026-03-26
- Completion
- 2026-05-26
- First posted
- 2026-02-04
- Last updated
- 2026-02-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07385534. Inclusion in this directory is not an endorsement.